The influence of therapy on outcome following BoNT-A injection for focal spasticity in adults with neurological conditions

THE EFFECTIVENESS OF THERAPY ON OUTCOME FOLLOWING BOTULINUM NEUROTOXIN INJECTION FOR FOCAL SPASTICITY IN ADULTS WITH NEUROLOGICAL CONDITIONS – SYSTEMATIC REVIEW

Presenter: Moore E

This Module addresses: 

Question: Does therapy following botulinum neurotoxin injection

for spasticity improve rehabilitation outcomes in adults with

neurological conditions?

Conclusion: There was insufficient evidence to support or refute the

effectiveness of any of the commonly prescribed adjunctive therapies

following botulinum neurotoxin injection for focal spasticity in adults.

Key Practice Points:

• Limited evidence exists supporting any specific treatment protocols

following botulinum neurotoxin injection.

• Clinical expertise guides the application of adjunctive therapies

following botulinum neurotoxin; therapists should continue to

provide therapy in conjunction with botulinum neurotoxin to optimize

rehabilitation outcomes.